REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2015

Jan 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2015-01-02

Reporting Person: SING GEORGE L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-01-02	Non-Qualified Stock Option (right to buy)	$413.33	A	10838.0	Acquired	2025-01-02	Common Stock (10838)	Direct

Footnotes

F1: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.